191 related articles for article (PubMed ID: 34718471)
21. Reflux esophagitis and its role in the pathogenesis of Barrett's metaplasia.
Souza RF
J Gastroenterol; 2017 Jul; 52(7):767-776. PubMed ID: 28451845
[TBL] [Abstract][Full Text] [Related]
22. Superoxide dismutase prevents development of adenocarcinoma in a rat model of Barrett's esophagus.
Piazuelo E; Cebrián C; Escartín A; Jiménez P; Soteras F; Ortego J; Lanas A
World J Gastroenterol; 2005 Dec; 11(47):7436-43. PubMed ID: 16437713
[TBL] [Abstract][Full Text] [Related]
23. Effects of refluxate pH values on duodenogastroesophageal reflux-induced esophageal adenocarcinoma.
Cheng P; Li JS; Gong J; Zhang LF; Chen RZ
World J Gastroenterol; 2011 Jul; 17(25):3060-5. PubMed ID: 21799654
[TBL] [Abstract][Full Text] [Related]
24. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
25. BMP4 Signaling Is Able to Induce an Epithelial-Mesenchymal Transition-Like Phenotype in Barrett's Esophagus and Esophageal Adenocarcinoma through Induction of SNAIL2.
Kestens C; Siersema PD; Offerhaus GJ; van Baal JW
PLoS One; 2016; 11(5):e0155754. PubMed ID: 27191723
[TBL] [Abstract][Full Text] [Related]
26. Endoscopic evaluation of esophago-gastro-jejunostomy in rat model of Barrett's esophagus.
Lu S; Lowe AW; Triadafilopoulos G; Hsiung PL; Hao Y; Crawford JM; Wang TD
Dis Esophagus; 2009; 22(4):323-30. PubMed ID: 19473210
[TBL] [Abstract][Full Text] [Related]
27. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
Clark GW; Smyrk TC; Burdiles P; Hoeft SF; Peters JH; Kiyabu M; Hinder RA; Bremner CG; DeMeester TR
Arch Surg; 1994 Jun; 129(6):609-14. PubMed ID: 8204035
[TBL] [Abstract][Full Text] [Related]
28. The treatment of Barrett's esophagus.
Hoara P; Gindea C; Birla R; Mocanu A; Tavlas E; Constantinoiu S
J Med Life; 2009; 2(3):241-8. PubMed ID: 20112466
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett's esophagus.
Sarosi G; Brown G; Jaiswal K; Feagins LA; Lee E; Crook TW; Souza RF; Zou YS; Shay JW; Spechler SJ
Dis Esophagus; 2008; 21(1):43-50. PubMed ID: 18197938
[TBL] [Abstract][Full Text] [Related]
30. High yield reproducible rat model recapitulating human Barrett's carcinogenesis.
Matsui D; Omstead AN; Kosovec JE; Komatsu Y; Lloyd EJ; Raphael H; Kelly RJ; Zaidi AH; Jobe BA
World J Gastroenterol; 2017 Sep; 23(33):6077-6087. PubMed ID: 28970723
[TBL] [Abstract][Full Text] [Related]
31. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
Yen CJ; Izzo JG; Lee DF; Guha S; Wei Y; Wu TT; Chen CT; Kuo HP; Hsu JM; Sun HL; Chou CK; Buttar NS; Wang KK; Huang P; Ajani J; Hung MC
Cancer Res; 2008 Apr; 68(8):2632-40. PubMed ID: 18413730
[TBL] [Abstract][Full Text] [Related]
32. Columnar metaplasia in a surgical mouse model of gastro-esophageal reflux disease is not derived from bone marrow-derived cell.
Aikou S; Aida J; Takubo K; Yamagata Y; Seto Y; Kaminishi M; Nomura S
Cancer Sci; 2013 Sep; 104(9):1154-61. PubMed ID: 23734763
[TBL] [Abstract][Full Text] [Related]
33. Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats.
Kumagai H; Mukaisho K; Sugihara H; Miwa K; Yamamoto G; Hattori T
Carcinogenesis; 2004 May; 25(5):723-7. PubMed ID: 14754873
[TBL] [Abstract][Full Text] [Related]
34. The sequential model of Barrett's esophagus and adenocarcinoma induced by duodeno-esophageal reflux without exogenous carcinogens.
Sato T; Miwa K; Sahara H; Segawa M; Hattori T
Anticancer Res; 2002; 22(1A):39-44. PubMed ID: 12017320
[TBL] [Abstract][Full Text] [Related]
35. [Cyclooxygenase (COX)-2 expression in a rat duodenoesophageal reflux model and chemoprevention of adenocarcinoma by the selective COX-2 inhibitor nimesulide].
Oyama K; Fujimura T; Ninomiya I; Miyashita T; Kinami S; Fushida S; Ohta T
Nihon Shokakibyo Gakkai Zasshi; 2007 Aug; 104(8):1183-91. PubMed ID: 17675820
[TBL] [Abstract][Full Text] [Related]
36. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.
Wang DH; Clemons NJ; Miyashita T; Dupuy AJ; Zhang W; Szczepny A; Corcoran-Schwartz IM; Wilburn DL; Montgomery EA; Wang JS; Jenkins NA; Copeland NA; Harmon JW; Phillips WA; Watkins DN
Gastroenterology; 2010 May; 138(5):1810-22. PubMed ID: 20138038
[TBL] [Abstract][Full Text] [Related]
37. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
[TBL] [Abstract][Full Text] [Related]
38. The pathogenesis of Barrett's metaplasia and the progression to esophageal adenocarcinoma.
Grotenhuis BA; van Lanschot JJ; Dinjens WN; Wijnhoven BP
Recent Results Cancer Res; 2010; 182():39-63. PubMed ID: 20676870
[TBL] [Abstract][Full Text] [Related]
39. An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload.
Chen X; Yang Gy; Ding WY; Bondoc F; Curtis SK; Yang CS
Carcinogenesis; 1999 Sep; 20(9):1801-8. PubMed ID: 10469627
[TBL] [Abstract][Full Text] [Related]
40. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence.
Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; Comber H; McGuigan J; Reynolds JV; Murray LJ
Cancer Res; 2006 May; 66(9):4975-82. PubMed ID: 16651456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
